Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
Authors:
- Joseph G. Schroers-MartinJSJoseph G. Schroers-Martin
- Joanne SooJSJoanne Soo
- Gabriel BrisouGBGabriel Brisou
- Florian SchererFSFlorian Scherer
- David M. KurtzDKDavid M. Kurtz
- Brian J. SworderBSBrian J. Sworder
- Michael S. KhodadoustMKMichael S. Khodadoust
- Michael C. JinMJMichael C. Jin
- Agnès BruABAgnès Bru
- Chih Long LiuCLChih Long Liu
- Henning StehrHSHenning Stehr
- Paolo VineisPVPaolo Vineis
Open Access
- 20 March 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 13 (6) , 1310-1323
Abstract
Follicular lymphomas (FL) are characterized by BCL2 translocations, often detectable in blood years before FL diagnosis, but also observed in aging healthy individuals, suggesting additional lesions are required for lymphomagenesis. We directly characterized early cooperating mutations by ultradeep sequencing of prediagnostic blood and tissue specimens from 48 subjects who ultimately developed FL. Strikingly, CREBBP lysine acetyltransferase (KAT) domain mutations were the most commonly observed precursor lesions, and largely distinguished patients developing FL (14/48, 29%) from healthy adults with or without detected BCL2 rearrangements (0/13, P = 0.03 and 0/20, P = 0.007, respectively). CREBBP variants were detectable a median of 5.8 years before FL diagnosis, were clonally selected in FL tumors, and appeared restricted to the committed B-cell lineage. These results suggest that mutations affecting the CREBBP KAT domain are common lesions in FL cancer precursor cells (CPC), with the potential for discriminating subjects at risk of developing FL or monitoring residual disease. Significance: Our study provides direct evidence for recurrent genetic aberrations preceding FL diagnosis, revealing the combination of BCL2 translocation with CREBBP KAT domain mutations as characteristic committed lesions of FL CPCs. Such prediagnostic mutations are detectable years before clinical diagnosis and may help discriminate individuals at risk for lymphoma development. This article is highlighted in the In This Issue feature, p. 1275Keywords
All Related Versions
Funding Information
- Damon Runyon Cancer Research Foundation (Clinical Investigator)
- American Society of Hematology (ASH Scholar)
- Leukemia and Lymphoma Society (Career Development Program)
- Stanford Cancer Institute (Innovation Award)
- Fondation ARC pour la Recherche sur le Cancer
- Association Instituts Carnot
- Canceropôle PACA (PACA Grant)
- Fondation pour la Recherche Médicale
- Deutsche Forschungsgemeinschaft (SCHE 1870/1-1)
- Bakewell Foundation
- Stanford Cancer Institute (2017 Stanford Cancer Fellow)
- Doris Duke Charitable Foundation (2016 Clinical Research Mentorship)
- National Cancer Institute (R01CA233975)
- National Institutes of Health (1U01 CA194389)
- American Association for Cancer Research (2021 Lymphoma Research Fellowship)
- National Institutes of Health (1-DP2-CA186569)
- Virginia and D.K. Ludwig Fund for Cancer Research
- Lymphoma Research Foundation (FL Pathways Award)
- Damon Runyon Cancer Research Foundation (PSTA)
This publication has 52 references indexed in Scilit:
- DELLY: structural variant discovery by integrated paired-end and split-read analysisBioinformatics, 2012
- BootstRatio: A web-based statistical analysis of fold-change in qPCR and RT-qPCR data using resampling methodsComputers in Biology and Medicine, 2012
- Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphomaBlood, 2011
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphomaNature, 2011
- Inactivating mutations of acetyltransferase genes in B-cell lymphomaNature, 2011
- Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma cloneBlood, 2008
- Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesisJournal of Experimental Medicine, 2006
- Clonal selection in the bone marrow involvement of follicular lymphomaLeukemia, 2005
- The American Cancer Society Cancer Prevention Study II Nutrition CohortCancer, 2002
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1982